Suppr超能文献

成功进行针对因子H相关性溶血尿毒综合征的肝肾联合移植

Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.

作者信息

Saland Jeffrey M, Shneider Benjamin L, Bromberg Jonathan S, Shi Patricia A, Ward Stephen C, Magid Margret S, Benchimol Corinne, Seikaly Mouin G, Emre Sukru H, Bresin Elena, Remuzzi Giuseppe

机构信息

Department of Pediatrics, The Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA.

出版信息

Clin J Am Soc Nephrol. 2009 Jan;4(1):201-6. doi: 10.2215/CJN.02170508. Epub 2008 Nov 12.

Abstract

BACKGROUND AND OBJECTIVES

A male infant with a family history of thrombotic microangiopathy developed atypical hemolytic uremic syndrome (aHUS).

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Case report.

RESULTS

Genetic analysis demonstrated a heterozygous mutation (S1191L) of CFH, the gene coding complement factor H (CFH). The child suffered many episodes of HUS, each treated with plasma exchange. In time, despite initiation of a prophylactic regimen of plasma exchange, his renal function declined significantly. At the age of 4 yr he received a (split liver) combined liver-kidney transplant (LKT) with preoperative plasma exchange and enoxaparin anticoagulation. Initial function of both grafts was excellent and is maintained for nearly 2 yr.

CONCLUSIONS

This report adds to the small but growing number of individuals in whom LKT has provided a favorable outcome for aHUS associated with CFH mutation, expands the technique of using a split liver graft, and describes the unique histologic features of subclinical liver disease in HUS.

摘要

背景与目的

一名有血栓性微血管病家族史的男婴患上了非典型溶血尿毒综合征(aHUS)。

设计、地点、参与者与测量方法:病例报告。

结果

基因分析显示编码补体因子H(CFH)的CFH基因存在杂合突变(S1191L)。该患儿多次发生溶血尿毒综合征,每次发作均接受血浆置换治疗。随着时间推移,尽管开始了血浆置换预防性治疗方案,但其肾功能仍显著下降。4岁时,他接受了(劈离式肝脏)肝肾联合移植(LKT),术前进行了血浆置换和依诺肝素抗凝。两个移植物的初始功能均良好,并维持了近2年。

结论

本报告增加了接受LKT治疗与CFH突变相关的aHUS并取得良好疗效的病例数量,尽管数量不多但仍在增加,扩展了使用劈离式肝脏移植物的技术,并描述了溶血尿毒综合征中亚临床肝脏疾病的独特组织学特征。

相似文献

1
Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.
Clin J Am Soc Nephrol. 2009 Jan;4(1):201-6. doi: 10.2215/CJN.02170508. Epub 2008 Nov 12.
4
Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H.
Am J Transplant. 2010 Sep;10(9):2142-7. doi: 10.1111/j.1600-6143.2010.03228.x. Epub 2010 Aug 11.
5
Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.
Am J Transplant. 2008 Jan;8(1):216-21. doi: 10.1111/j.1600-6143.2007.02029.x. Epub 2007 Oct 31.
9
Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?
Nephrol Dial Transplant. 2009 Nov;24(11):3548-51. doi: 10.1093/ndt/gfp377. Epub 2009 Jul 25.

引用本文的文献

2
Combined liver-kidney transplantation for rare diseases.
World J Hepatol. 2020 Oct 27;12(10):722-737. doi: 10.4254/wjh.v12.i10.722.
3
Haemolytic uremic syndrome: diagnosis and management.
F1000Res. 2019 Sep 25;8. doi: 10.12688/f1000research.19957.1. eCollection 2019.
5
Guidelines for the management and investigation of hemolytic uremic syndrome.
Clin Exp Nephrol. 2014 Aug;18(4):525-57. doi: 10.1007/s10157-014-0995-9.
6
Anesthetic management of living donor liver transplantation for complement factor H deficiency hemolytic uremic syndrome: a case report.
Korean J Anesthesiol. 2014 Jun;66(6):481-5. doi: 10.4097/kjae.2014.66.6.481. Epub 2014 Jun 26.
8
Hemolytic uremic syndrome.
Semin Immunopathol. 2014 Jul;36(4):399-420. doi: 10.1007/s00281-014-0416-x. Epub 2014 Feb 14.
9
Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?
Pediatr Nephrol. 2014 Mar;29(3):329-32. doi: 10.1007/s00467-013-2722-2. Epub 2013 Dec 22.
10
Atypical hemolytic uremic syndrome.
Semin Nephrol. 2013 Nov;33(6):508-30. doi: 10.1016/j.semnephrol.2013.08.003.

本文引用的文献

1
Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.
Am J Transplant. 2008 Jan;8(1):216-21. doi: 10.1111/j.1600-6143.2007.02029.x. Epub 2007 Oct 31.
2
Gastrointestinal complications of post-diarrheal hemolytic uremic syndrome.
Eur J Pediatr Surg. 2007 Oct;17(5):328-34. doi: 10.1055/s-2007-965013.
4
New approaches to the treatment of dense deposit disease.
J Am Soc Nephrol. 2007 Sep;18(9):2447-56. doi: 10.1681/ASN.2007030356. Epub 2007 Aug 5.
5
Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
Mol Immunol. 2008 Jan;45(1):95-105. doi: 10.1016/j.molimm.2007.05.004. Epub 2007 Jun 26.
6
Thrombotic microangiopathy and intravenous immunoglobulin therapy.
Pediatr Nephrol. 2007 Jun;22(6):907-8; author reply 909. doi: 10.1007/s00467-007-0441-2. Epub 2007 Feb 13.
7
A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome.
Pediatr Nephrol. 2007 Mar;22(3):371-5. doi: 10.1007/s00467-006-0320-2. Epub 2006 Nov 15.
9
Intravenous gamma globulin for thrombotic microangiopathy of unknown etiology.
Pediatr Nephrol. 2007 Feb;22(2):301-5. doi: 10.1007/s00467-006-0326-9. Epub 2006 Oct 21.
10
Secondary failure of plasma therapy in factor H deficiency.
Pediatr Nephrol. 2006 Nov;21(11):1769-71. doi: 10.1007/s00467-006-0237-9. Epub 2006 Aug 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验